Bachrodt Amy bought MAZE
December 29, 2025 · Form 4 insider transaction
Bachrodt Amy bought 124 shares of Maze Therapeutics, Inc. at $10.42 per share, a transaction worth $1.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
124
Price
$10.42
Total value
$1.3K
InsiderBachrodt Amy
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 29, 2025
Filing dateDecember 31, 2025
Shares owned after13,089
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.